cefixime has been researched along with ro13-9904 in 145 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (2.76) | 18.7374 |
1990's | 16 (11.03) | 18.2507 |
2000's | 18 (12.41) | 29.6817 |
2010's | 68 (46.90) | 24.3611 |
2020's | 39 (26.90) | 2.80 |
Authors | Studies |
---|---|
Agoki, E; D'Costa, LJ; Ndinya-Achola, JO; Ombette, J; Plourde, PJ; Plummer, FA; Slaney, LA; Tyndall, M | 1 |
Holdcroft, C | 1 |
Covino, JM; Douglas, JM; Ehret, JM; Handsfield, HH; Hook, EW; McCormack, WM; Reichart, CA; Verdon, MS | 1 |
Cates, W; Hinman, AR | 1 |
Himes, SL; Mortensen, JE | 1 |
Regnier, B | 1 |
Noel, GJ; Teele, DW | 1 |
Knapp, CC; Sierra-Madero, J; Washington, JA | 1 |
Cullmann, W; Dick, W; Opferkuch, W; Stieglitz, M | 1 |
Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
Vartiovaara, I | 1 |
Bhutta, ZA; Khan, IA; Molla, AM | 1 |
Biro, FM; Friedland, LR; Kulick, RM; Patterson, A | 1 |
Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL | 1 |
Amir, J; Eidlitz-Markus, T; Harel, L; Varsano, I | 1 |
de Bruine, AP; Peters, FP; Stockbrügger, RW; Wouters, RS | 1 |
Bhutta, ZA; Hussain, R; Mansoorali, N | 1 |
Verbist, L; Verhaegen, J | 1 |
Nikoskelainen, J; Oksi, J; Viljanen, MK | 1 |
Agbaba, D; Eric-Jovanovic, S; Vladimirov, S; Zivanov-Stakic, D | 1 |
Barash, JR; Janda, JM; Sandfort, RF; Wong, JD | 1 |
Ambrose, PG; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Tessier, P | 1 |
Mayfield, JA; Ramus, RM; Sheffield, JS; Wendel, GD | 1 |
Joshi, VR; Mehta, A; Rodrigues, C | 1 |
Collvinent, B; Horcajada, JP; Marco, F; Mensa, J; Millá, J; Miró, O; Moreno, A; Sanchez, M | 1 |
Levenson, D | 2 |
Castello, B; Cohen, R; de La Vaissière, B; Grimprel, E; Quinet, B | 1 |
Little, JW | 1 |
Marth, T | 1 |
Fredlund, H; Lindberg, R; Nicholas, R; Unemo, M | 1 |
Deguchi, T; Ito, S; Kubota, Y; Maeda, S; Ozawa, T; Tamaki, M; Yasuda, M; Yokoi, S | 1 |
Furuya, R; Iyoda, T; Kanayama, A; Kobayashi, I; Matsuzaki, K; Onoye, Y; Saika, T; Tanaka, M; Tatewaki, M | 1 |
Bacelle, L; Chiesa, G; Dalla Vestra, M; Marcon, L; Patrassi, GM; Rettore, C; Sartore, P; Sasset, L; Scarano, L; Simioni, N; Velo, E | 1 |
Endo, K; Kiyota, H; Narukawa, K; Onodera, S; Osaka, K; Takahata, M; Takakura, T | 1 |
Tapsall, JW | 1 |
Davies, C; Duncan, M; Nicholas, RA; Tomberg, J; Unemo, M; Zhao, S | 1 |
Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E | 1 |
Chong, Y; Chung, GT; Jeong, SH; Lee, H; Lee, K; Lee, SG; Lee, YS; Yong, D | 1 |
Brill, JR | 1 |
Ojani, R; Raoof, JB; Zamani, S | 1 |
Davies, C; Nicholas, RA; Tomberg, J; Unemo, M | 1 |
Fredlund, H; Golparian, D; Hellmark, B; Unemo, M | 1 |
Jacobsson, S; Nissen, MD; Sloots, TP; Tapsall, JW; Unemo, M; Whiley, DM | 1 |
Klingler, A | 1 |
Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L | 1 |
Golparian, D; Moi, H; Syversen, G; Unemo, M; Vestrheim, DF | 1 |
Hogan, T; Kahlmeter, J; Lam, A; Limnios, A; Ray, S; Tapsall, J; Unemo, M | 1 |
Antonetti, R; Carannante, A; Cavrini, F; Cusini, M; D'Antuono, A; Dal Conte, I; Ghisetti, V; Matteelli, A; Prignano, G; Stefanelli, P | 1 |
Alexander, S; Ison, CA | 1 |
Bala, M | 1 |
Gallay, A; Golparian, D; Nicholas, R; Ohnishi, M; Sednaoui, P; Unemo, M | 1 |
Bocquet, N; Chéron, G; Gajdos, V; Guigonis, V; Jais, JP; Lacour, B; Sergent Alaoui, A | 1 |
Allen, V; Gilmour, M; Hoang, L; Lefebvre, B; Martin, I; Mina, N; Sawatzky, P; Wong, T | 1 |
Bai, ZG; Bao, XJ; Cheng, WD; Li, YP; Yang, KH | 1 |
Deguchi, T; Ito, S; Yasuda, M | 1 |
Bolan, G; Kidd, S; Kirkcaldy, R; Weinstock, H | 1 |
Cole, MJ; Ison, CA; Pereira, R | 1 |
Maldonado, NG; Takhar, SS | 1 |
Chisholm, S; Hughes, G; Ison, CA; Livermore, DM; Lowndes, CM; Obi, C; Town, K | 2 |
Azadian, B; Wright, DJ | 1 |
Fasih, N; Irfan, S; Khan, E; Qaiser, S; Sultan, BA; Zafar, A | 1 |
Dorin, M; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
Drews, SJ; Gratrix, J; Lovgren, M; Martin, I; Read, R; Romanowski, B; Singh, AE; Sutherland, K; Talbot, J | 1 |
Katz, AR; Kidd, S; Kirkcaldy, RD; Komeya, A; Kunimoto, G; Lee, MV; Maningas, E; O'Connor, N; Wasserman, GM; Whelen, AC | 1 |
Brooks, B; Cole, M; Patel, R; Ross, JD; Unemo, M; White, JA | 1 |
de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R | 1 |
Dillon, JA; Horsman, GB; Levett, PN; Thakur, SD | 1 |
Dillon, JR; Horsman, GB; Levett, PN; Starnino, S; Thakur, SD | 1 |
Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R | 1 |
Berçot, B; Cambau, E; La Ruche, G; Sednaoui, P; Semaille, C | 1 |
Deguchi, T; Ito, S; Tsuchiya, T; Yasuda, M; Yokoi, S | 1 |
Donovan, B; Lahra, MM; Whiley, DM | 1 |
Barbee, LA | 1 |
Furubayashi, K; Kawahata, T; Morita-Ishihara, T; Nakayama, S; Ohnishi, M; Shimuta, K; Unemo, M | 1 |
Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M | 1 |
Cheng, CW; Li, LH; Li, SY; Su, CY; Yen, MY | 1 |
Amato-Gauci, AJ; Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Town, K; Unemo, M; van de Laar, M | 1 |
Akiyama, K; Arakawa, S; Chokyu, H; Egawa, S; Fujisawa, M; Hamasuna, R; Hanaki, H; Hayami, H; Hirayama, H; Hosobe, T; Imai, T; Ishikawa, K; Ito, K; Ito, M; Ito, S; Iwata, S; Kadena, H; Kadota, J; Kaji, S; Kaku, M; Kano, M; Kawahara, M; Kawai, S; Kiyota, H; Kobayashi, K; Kumon, H; Kuroiwa, K; Maeda, S; Matsubara, A; Matsumoto, T; Matsumura, M; Minamitani, S; Monden, K; Naito, S; Narita, H; Nishi, S; Nishimura, H; Sato, J; Shirane, T; Sumii, T; Sunakawa, K; Takahashi, S; Takayama, K; Tanaka, K; Tsukamoto, T; Uehara, S; Uno, S; Watanabe, A; Yamaguchi, T; Yamamoto, S; Yasuda, M; Yoh, M; Yoshioka, M | 1 |
Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C | 1 |
Bogdan, M; Hećimović, I; Vuković, D; Zujić Atalić, V | 1 |
Mahboob, A; Nazeer, SH; Nizammudin, S; Raza, A; Sultan, F | 1 |
Saeed, NK | 1 |
Galarza, P; Gianecini, R; Oviedo, C; Stafforini, G | 1 |
Antonetti, R; Carannante, A; Cusini, M; Ghisetti, V; Latino, MA; Leli, C; Matteelli, A; Ober, P; Poletti, F; Prignano, G; Stefanelli, P; Vacca, P; Vocale, C | 1 |
Amarsy, R; Bercot, B; Cambau, E; de Curraize, C; Fournet, N; Goubard, A; Jacquier, H; Kumanski, S; La Ruche, G; Meunier, F; Micaëlo, M | 1 |
Althaus, CL; Foerster, S; Hathaway, LJ; Low, N; Unemo, M | 1 |
Brunner, A; Jeney, C; Karpati, S; Marschalko, M; Nemes-Nikodem, E; Ostorhazi, E; Szabo, D | 1 |
Abrams, JA; Barros Dos Santos, KT; Bonelli, RR; Coelho-Souza, T; Costa-Lourenço, APR; Fracalanzza, SEL; Moreira, BM; Trees, DL | 1 |
Chen, SC; Chen, XS; Dai, XQ; Han, Y; Yin, Y; Yu, RX; Zhang, GY; Zheng, BJ | 1 |
Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
Chakanyuka Musanhu, C; Gudza-Mugabe, M; Gwanzura, L; Latif, AS; Machiha, A; Ndowa, F; Shukusho, FD; Tarupiwa, A; Unemo, M; Wi, T | 1 |
Galarza, P; Gianecini, R; Oviedo, C; Romero, MLM; Vacchino, M | 1 |
Amato-Gauci, AJ; Cole, MJ; Jacobsson, S; Spiteri, G; Tripodo, F; Unemo, M; Woodford, N | 1 |
Dillon, JR; Horsman, GB; Levett, PN; Thakur, SD | 1 |
Glennen, A; Hagan, C; Iwen, PC; Lee, LV; O'Connor, NP; Papp, JR; Razeq, JH; Rowlinson, MC; Ware, D; Wholehan, J | 1 |
Bremer, V; Buder, S; Dudareva, S; Guhl, E; Jansen, K; Kohl, PK; Loenenbach, A; Nikisins, S; Sailer, A | 1 |
Comunián-Carrasco, G; Martí-Carvajal, AJ; Peña-Martí, GE | 1 |
Cole, MJ; Ison, C; Woodford, N | 1 |
Furuya, R; Kanesaka, I; Katsuse, AK; Kobayashi, I; Ohno, A; Tanaka, M | 1 |
Amato-Gauci, AJ; Cole, MJ; Day, MJ; Jacobsson, S; Spiteri, G; Unemo, M; Woodford, N | 1 |
Davies, C; Nicholas, RA; Singh, A; Tomberg, J | 1 |
Deng, X; Klausner, JD | 1 |
Majewska, A; Majewski, S; Malejczyk, M; Młynarczyk, G; Młynarczyk-Bonikowska, B | 1 |
Indriatmi, W; Nilasari, H; Prayogo, RL; Suseno, LS | 1 |
Dobre-Buonya, O; Kilic, A; McNeil, CJ; Palavecino, EL; Schmerer, MW; Toler, C | 1 |
Hamill, MM; Kajumbula, H; Kakooza, F; Kyambadde, P; Lamorde, M; Manabe, YC; Mande, E; Mbabazi, O; Mugasha, R; Musinguzi, P; Wagner, J; Walwema, R; Workneh, M; Zenilman, J | 1 |
Borrego, MJ; Duarte, S; Gomes, JP; Gonçalves, I; Gonçalves, MJ; Matias, R; Pinto, M; Ramos, MH; Rodrigues, JC; Vieira, L | 1 |
Buder, S; Dudareva, S; Eckardt, M; Gassowski, M; Graeber, I; Guhl, E; Heuer, D; Jansen, K; Selb, R; Tamminga, T | 1 |
Dresser, J; Wilby, KJ | 1 |
Adelman, E; Barber, L; Bautista, I; Bendik, W; Griego, R; Hansen, H; Kersh, EN; Knoblock, RJ; Lam, K; Pham, CD; Picker, MA; Qiu-Shultz, Z; Raphael, BH; St Cyr, SB; Weinstock, H | 1 |
Cole, MJ; Day, M; Jacobsson, S; Spiteri, G; Unemo, M | 1 |
Abbai, NS; Maise, HC; Naicker, M; Oree, G; Ramsuran, V; Tinarwo, P | 1 |
Abe, S; Amarasiri, M; Badavath, VN; Chantaravisoot, N; Chatsuwan, T; Higgins, PG; Hongsing, P; Hurst, C; Jenjaroenpun, P; Kerr, SJ; Kueakulpattana, N; Luk-In, S; Phattharapornjaroen, P; Saethang, T; Shein, AMS; Teeratakulpisan, N; Wannigama, DL; Wongsurawat, T | 1 |
Bonongwe, N; Chen, JS; Chikaonda, T; Cohen, MS; Golparian, D; Hobbs, MM; Hoffman, IF; Jere, E; Kamtambe, B; Krysiak, R; Massa, C; Mathiya, E; Matoga, M; Ndalama, B; Unemo, M | 1 |
Allen, H; Cole, MJ; Fifer, H; Hughes, G; Ivanov, Z; Merrick, R; Mohammed, H; Pitt, R; Sinka, K | 1 |
Cai, C; Cao, W; Chen, H; Guo, C; Li, M; Liao, Y; Lin, X; Liu, X; Pei, J; Qin, X; Tang, S; Wang, F; Wu, S; Wu, X; Wu, Z; Xie, Q; Yu, Y; Zheng, H | 1 |
Cole, MJ; Dillon, JR; Eremin, S; Escher, M; Galarza, P; Galas, M; Lahra, MM; Martin, I; Ndowa, F; Ramon-Pardo, P; Unemo, M; Weinstock, H; Wi, T | 1 |
Aanensen, DM; Abudahab, K; Bluemel, B; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sajedi, N; Sánchez-Busó, L; Spiteri, G; Underwood, A; Unemo, M; Yeats, CA | 1 |
Amato-Gauci, AJ; Blumel, B; Cole, MJ; Day, MJ; Jacobsson, S; Kulishev, C; Sajedi, N; Spiteri, G; Unemo, M; van der Werf, MJ; Woodford, N | 1 |
Nguyen, HT; Nguyen, HV; Nguyen, PTT; Pham, HV; Pham, LV; Van, DH | 1 |
Adamson, PC; Allan-Blitz, LT; Klausner, JD | 1 |
Barrios-Cárdenas, YJ; Benites, C; Jorge-Berrocal, A; Mayta-Barrios, M; Melano, RG; Salazar-Quispe, F; Vargas-Herrera, N; Yagui, M | 1 |
Jenjaroenpun, P; Nitayanon, P; Nokchan, N; Tribuddharat, C; Wongsurawat, T | 1 |
Akeda, Y; Nakayama, SI; Ohnishi, M; Shimuta, K; Takahashi, H | 1 |
Kiamos, A; Sands, M; Torrente, N; Verdecia, J | 1 |
Kowalewski, C; Krolak-Ulinska, A; Marusza, W; Mlynarczyk-Bonikowska, B | 1 |
Alvarado, L; Burghardt, NO; Hernandez, C; Hughes, B; Jacobson, KR; Jenkins-Barnes, T; Johnson, KA; Lopez, E; Salas, KL; Tang, EC | 1 |
Debelo, M; Mohammed, N; Tiruneh, A; Tolosa, T | 1 |
Chow, EPF; Fairley, CK; Hammoud, MA; Hocking, JS; Kong, FYS; Landersdorfer, CB; Latch, N; Lewis, DA; Lim, SH; Parker, SL; Roberts, JA; Unemo, M; Wallis, SC; Williamson, DA; Yap, T | 1 |
Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
Bristow, CC; Klausner, JD; Kojima, N; Yang, KJ | 1 |
Cao, W; Dong, Y; Gu, W; Hu, L; Huang, J; Li, Y; Peng, J; Wang, L; Wang, Y; Xiu, L; Yong, G | 1 |
Ahmad, M; Shah, N; Siddiqui, MA | 1 |
Jain, SH; Lee, CY; Li, JW; Lin, HH; Lin, SY; Lu, PL; Yang, TY | 1 |
Allen, H; Althaus, CL; Cole, MJ; Grad, YH; Heijne, JCM; Low, N; Riou, J; Unemo, M | 1 |
Feng, Z; Li, X; Liao, Y; Liu, M; Pan, Y; Qin, X; Wu, X; Xie, Q; Yang, J; Yin, X; Zeng, L; Zheng, H | 1 |
Chen, W; Li, R; Lin, X; Liu, X; Luo, X; Tang, Y; Zhuang, P | 1 |
Blouin, K; Defay, F; Ezin Aloffan, LND; Labbé, AC; Lefebvre, B; Perrault Sullivan, G; Trudelle, A | 1 |
Chokyu, H; Fujita, R; Hamasuna, R; Hanaki, H; Hara, M; Hatano, K; Hayami, H; Hayashi, K; Hirayama, H; Hiyama, Y; Hosobe, T; Ihara, H; Inokuchi, J; Ishikawa, K; Ito, K; Ito, M; Ito, S; Izumitani, M; Kadena, H; Kaji, S; Kano, M; Kawahara, M; Kawai, S; Kimura, T; Kiyota, H; Kobayashi, K; Kurimura, Y; Maruyama, T; Masumori, N; Matsumoto, K; Matsumoto, M; Matsumoto, T; Matsumura, M; Miyazaki, J; Monden, K; Naito, K; Nishi, S; Nishimura, H; Nishiyama, H; Sadahira, T; Sato, J; Shiono, Y; Sumii, T; Takahashi, S; Takayama, K; Tanaka, K; Togo, Y; Tojo, T; Uno, S; Wada, K; Yamada, H; Yamamoto, S; Yasuda, M; Yoh, M; Yokoyama, T; Yotsuyanagi, H | 1 |
Dingle, TC; Ferrato, C; Gratrix, J; Ma, A; Martin, I; Smyczek, P | 1 |
12 review(s) available for cefixime and ro13-9904
Article | Year |
---|---|
[Whipple's disease].
Topics: Anti-Bacterial Agents; Biopsy; Cefixime; Ceftriaxone; Clinical Trials as Topic; Doxycycline; Duodenum; Humans; Intestinal Mucosa; Jejunum; Male; Meropenem; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Thienamycins; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Whipple Disease | 2007 |
Acute pyelonephritis in children: antibiotic therapy depending on the clinical context.
Topics: Acute Disease; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Child, Preschool; Humans; Microbial Sensitivity Tests; Practice Guidelines as Topic; Pyelonephritis; Risk Factors | 2010 |
Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Disease Management; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Microbial Interactions; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Plasmids; Population Surveillance; Public Health; Treatment Failure; United Kingdom | 2011 |
Efficacy and safety of ceftriaxone for uncomplicated gonorrhoea: a meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gonorrhea; Humans; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Spectinomycin; Treatment Outcome | 2012 |
Preparing for an era of untreatable gonorrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Administration Schedule; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharynx; Population Surveillance; Practice Guidelines as Topic; Public Health; Treatment Failure | 2014 |
Salmonella pneumonia complicated with encysted empyema in an immunocompromised youth: Case report and literature Review.
Topics: Anti-Bacterial Agents; Bahrain; Cefixime; Ceftriaxone; Empyema; Hodgkin Disease; Humans; Male; Pneumonia, Bacterial; Salmonella enteritidis; Salmonella Infections; Sputum; Young Adult | 2016 |
Antibiotics for treating gonorrhoea in pregnancy.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Female; Gonorrhea; Humans; Pregnancy; Pregnancy Complications, Infectious; Probenecid; Randomized Controlled Trials as Topic; Spectinomycin | 2018 |
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Europe; Genotype; Gonorrhea; Humans; Neisseria gonorrhoeae; Penicillins | 2020 |
Safety of Single-Dose Oral Cefixime, Intramuscular Ceftriaxone, or Intramuscular Gentamicin for the Treatment of Gonorrhea: A Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gentamicins; Gonorrhea; Humans; Injections, Intramuscular | 2021 |
Molecular Mechanisms of Drug Resistance and Epidemiology of Multidrug-Resistant Variants of
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cefixime; Ceftriaxone; Drug Resistance; Drug Resistance, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillinase; Penicillins; Peptidyl Transferases | 2022 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
Effectiveness of Cefixime for the Treatment of Neisseria gonorrhoeae Infection at 3 Anatomic Sites: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Treatment Outcome | 2023 |
16 trial(s) available for cefixime and ro13-9904
Article | Year |
---|---|
Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Drug Evaluation; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Urethritis; Uterine Cervicitis | 1992 |
Cefixime offers effective oral therapy for gonorrhea.
Topics: Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Ceftriaxone; Female; Gonorrhea; Humans; Male | 1992 |
A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Ceftriaxone; Drug Resistance, Microbial; Drug Tolerance; Female; Gonorrhea; Humans; Injections, Intramuscular; Male | 1991 |
[Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftriaxone; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Random Allocation; Urinary Tract Infections | 1989 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftriaxone; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Infant; Injections, Intravenous; Male; Salmonella typhi; Typhoid Fever | 1994 |
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial Infections; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Outpatients; Patient Compliance | 1996 |
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillins; Pneumonia, Pneumococcal; Radiography | 1996 |
Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome.
Topics: Adolescent; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Interleukin-6; Male; Morbidity; Salmonella typhi; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Typhoid Fever | 1997 |
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Lyme Disease; Penicillins; Probenecid; Renal Agents; Treatment Outcome | 1998 |
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Cefixime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross-Over Studies; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
Topics: Administration, Oral; Adolescent; Adult; Anus Diseases; Cefixime; Ceftriaxone; Cephalosporins; Chlamydia Infections; Female; Gonorrhea; Humans; Injections, Intramuscular; Pharyngeal Diseases; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Treatment Outcome; Uterine Cervical Diseases | 2001 |
Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial.
Topics: Acute Disease; Adult; Cefixime; Ceftriaxone; Cephalosporins; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis | 2002 |
Randomized trial of oral versus sequential IV/oral antibiotic for acute pyelonephritis in children.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Calcitonin; Calcitonin Gene-Related Peptide; Cefixime; Ceftriaxone; Child, Preschool; Drug Administration Schedule; Escherichia coli Infections; Female; Humans; Infant; Infusions, Intravenous; Male; Prospective Studies; Protein Precursors; Pyelonephritis; Radionuclide Imaging | 2012 |
Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Coinfection; Doxycycline; Gonorrhea; Humans; Neisseria gonorrhoeae | 2022 |
Optimisation of treatments for oral
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2022 |
117 other study(ies) available for cefixime and ro13-9904
Article | Year |
---|---|
Sexually transmitted diseases in the 1990s.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Gonorrhea; HIV Infections; Humans; Sexually Transmitted Diseases | 1991 |
Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.
Topics: Ampicillin Resistance; beta-Lactamases; Cefixime; Cefotaxime; Ceftriaxone; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests | 1990 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
Topics: Bacteria; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Microbial Sensitivity Tests | 1988 |
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Plasmids | 1988 |
Living with Lyme.
Topics: Adaptation, Psychological; Adult; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Finland; History, 20th Century; Humans; Lyme Disease; Male | 1995 |
Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Female; Gonorrhea; Humans; Injections, Intramuscular; Treatment Outcome; Uterine Cervicitis | 1996 |
Cerebral relapse of sarcoidlike Whipple's disease.
Topics: Brain Diseases; Cefixime; Cefotaxime; Ceftriaxone; Diagnosis, Differential; Humans; Male; Middle Aged; Recurrence; Sarcoidosis; Whipple Disease | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dosage Forms; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Yersinia pestis | 2000 |
Salmonella typhiin the past decade: learning to live with resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 2002 |
Sexually transmitted disease guidelines focus on prevention.
Topics: Bisexuality; California; Cefixime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Bacterial; Female; Fluoroquinolones; Homosexuality, Male; Humans; Infertility; Male; Mass Screening; Pelvic Inflammatory Disease; Practice Guidelines as Topic; Risk Factors; Sexually Transmitted Diseases; United States | 2002 |
Increasing cases of drug-resistant gonorrhea prompt new CDC treatment recommendations for gay and bisexual men.
Topics: Cefixime; Ceftizoxime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Contraindications; Drug Resistance; Fluoroquinolones; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Practice Guidelines as Topic; United States | 2004 |
[Management of acute pyelonephritis in patients older than 3 months: survey conducted in 39 paediatric emergency departments of the Ile de France Region in 2004].
Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Anti-Bacterial Agents; Cefaclor; Cefixime; Ceftriaxone; Child; Child, Preschool; Data Collection; Drug Therapy, Combination; Emergency Service, Hospital; Follow-Up Studies; France; Humans; Infant; Infusions, Parenteral; Injections, Intravenous; Intensive Care Units, Pediatric; Outpatients; Pyelonephritis; Surveys and Questionnaires; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Ultrasonography; Urethra; Urinary Bladder; Urography | 2006 |
Gonorrhea: update.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Gonorrhea; Humans; Incidence; Infection Control, Dental; Neisseria gonorrhoeae; Oral Ulcer; Pharyngitis; Prevalence; United States | 2006 |
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Polymorphism, Genetic; Porins; Repressor Proteins | 2007 |
Threat to cefixime treatment for gonorrhea.
Topics: Adult; Base Sequence; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae | 2007 |
Antimicrobial resistance in clinical isolates of Neisseria subflava from the oral cavities of a Japanese population.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Japan; Male; Microbial Sensitivity Tests; Mouth; Neisseria; Penicillins; Tetracycline | 2007 |
Acute septic arthritis: remember gonorrhea.
Topics: Acute Disease; Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Gonorrhea; Humans; Knee Joint; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Treatment Outcome | 2008 |
Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Sequence Analysis, Protein; Urethritis | 2008 |
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Australia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Dose-Response Relationship, Drug; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pacific Islands; Treatment Failure; World Health Organization | 2009 |
Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance | 2009 |
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone.
Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature | 2009 |
Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; DNA Fingerprinting; DNA, Bacterial; Genotype; Humans; Korea; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Neisseria gonorrhoeae; Sequence Analysis, DNA | 2010 |
Diagnosis and treatment of urethritis in men.
Topics: Adolescent; Adult; Azithromycin; Black or African American; Cefixime; Ceftriaxone; Chlamydia Infections; Chlamydia trachomatis; Contact Tracing; Doxycycline; Drug Therapy, Combination; Gonorrhea; HIV Infections; Humans; Male; Mycoplasma Infections; Ureaplasma Infections; Urethritis; White People; Young Adult | 2010 |
A novel sensor for cephalosporins based on electrocatalytic oxidation by poly(o-anisidine)/SDS/Ni modified carbon paste electrode.
Topics: Aniline Compounds; Biosensing Techniques; Catalysis; Cefixime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chemistry Techniques, Analytical; Electrochemistry; Electrodes; Models, Chemical; Nickel; Oxygen; Sodium Dodecyl Sulfate; Solvents | 2010 |
Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Penicillins | 2010 |
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antigens, Bacterial; Cefixime; Ceftriaxone; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Female; Genome, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Neisseria gonorrhoeae; Phylogeny; Sweden; Young Adult | 2010 |
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporin Resistance; Fimbriae Proteins; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Neisseria gonorrhoeae | 2010 |
Quick recertification series. Gonorrhea.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Risk Factors | 2010 |
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norway; Polymerase Chain Reaction; Treatment Failure | 2010 |
Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
Topics: Alleles; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gonorrhea; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Sequence Analysis, DNA | 2011 |
Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Population Surveillance; United States | 2011 |
Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Italy; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Typing; Mutant Proteins; Neisseria gonorrhoeae; Sequence Analysis, DNA | 2012 |
Characterization of profile of multidrug-resistant Neisseria gonorrhoeae using old and new definitions in India over a decade: 2000-2009.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; India; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2011 |
High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
Topics: Alleles; Amino Acid Sequence; Anti-Bacterial Agents; Biomarkers; Cefixime; Ceftriaxone; Cephalosporin Resistance; France; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Mosaicism; Multilocus Sequence Typing; Neisseria gonorrhoeae; Population Surveillance; Porins; Treatment Failure | 2012 |
Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
Topics: Adolescent; Adult; Canada; Cefixime; Ceftriaxone; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult | 2012 |
Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporin Resistance; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2012 |
Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Centers for Disease Control and Prevention, U.S.; Doxycycline; Drug Administration Schedule; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Neisseria gonorrhoeae; United States | 2012 |
Tackling multidrug-resistant gonorrhea: how should we prepare for the untreatable?
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Public Health; Treatment Failure | 2012 |
Combination therapy for gonorrhoea: in vitro synergy testing.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Synergism; Gentamicins; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; United Kingdom | 2013 |
Update on Emerging Infections: news from the Centers for Disease Control and Prevention. Update to the CDC’s Sexually Transmitted Diseases Treatment Guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections .
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Doxycycline; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2013 |
Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; England; Female; Genes, Bacterial; Gonorrhea; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Porins; Prevalence; Risk Factors; Sexual Behavior; Wales; Young Adult | 2013 |
Cephalosporin resistance in gonorrhoea.
Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2013 |
Mixed Salmonella infection: a report of two cases from the Aga Khan University Hospital, Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefixime; Ceftriaxone; Child, Preschool; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Salmonella Infections; Salmonella paratyphi A; Salmonella typhi | 2013 |
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; beta-Lactam Resistance; Cefixime; Ceftriaxone; Ciprofloxacin; Epidemiological Monitoring; Female; Gonorrhea; Humans; Incidence; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillin G | 2013 |
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Topics: Alberta; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality, Female; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Retrospective Studies | 2013 |
Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Hawaii; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Population Surveillance; Prevalence; Young Adult | 2013 |
Does the '2012 IUSTI ECCG report on the diagnosis and management of Neisseria gonorrhoeae infections in Europe' depict the situation in Europe?
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Disease Management; Europe; Gonorrhea; Health Services Accessibility; Health Surveys; Humans; Neisseria gonorrhoeae; Nucleic Acid Amplification Techniques; Surveys and Questionnaires | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult | 2013 |
Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Female; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Neisseria gonorrhoeae; Penicillins; Saskatchewan; Sequence Analysis, DNA; Spectinomycin; Tetracycline; Young Adult | 2014 |
Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
Topics: Amino Acid Substitution; Bacterial Proteins; Canada; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae | 2014 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult | 2014 |
Decreased susceptibility to cephalosporins among gonococci?
Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2014 |
Decreased susceptibility to cephalosporins among gonococci?
Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2014 |
Decreased susceptibility to cephalosporins among gonococci? Authors' reply.
Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2014 |
Decreased susceptibility to cephalosporins among gonococci?
Topics: Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae | 2014 |
Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Promoter Regions, Genetic; Repressor Proteins; RNA, Ribosomal, 23S; Spectinomycin; Treatment Failure | 2014 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance | 2014 |
Changes in the six most common sequence types of Neisseria gonorrhoeae, including ST4378, identified by surveillance of antimicrobial resistance in northern Taiwan from 2006 to 2013.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Ciprofloxacin; Condoms; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Penicillins; Sexual and Gender Minorities; Taiwan; Unsafe Sex | 2016 |
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.
Topics: Adult; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Microbial; Europe; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Risk Factors; Sentinel Surveillance | 2014 |
The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Population Surveillance; Urethritis; Young Adult | 2015 |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2015 |
Brain abscess due to Aggregatibacter aphrophilus and Bacteroides uniformis.
Topics: Adolescent; Aggregatibacter aphrophilus; Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; Brain Abscess; Cefixime; Ceftriaxone; Coinfection; Craniotomy; Drainage; Humans; Magnetic Resonance Imaging; Male; Metronidazole; Pasteurellaceae Infections | 2015 |
Shigella infections: A two year experience in cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Child; Child, Preschool; Comorbidity; Drug Resistance, Bacterial; Dysentery, Bacillary; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Pakistan; Retrospective Studies; Shigella flexneri; Young Adult | 2016 |
Neisseria gonorrhoeae Resistant to Ceftriaxone and Cefixime, Argentina.
Topics: Alleles; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; Cefixime; Ceftriaxone; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Young Adult | 2016 |
Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy.
Topics: Alleles; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Italy; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Promoter Regions, Genetic | 2017 |
Ceftriaxone-Resistant Neisseria gonorrhoeae Isolates (2010 to 2014) in France Characterized by Using Whole-Genome Sequencing.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cell Cycle Proteins; Cephalosporin Resistance; France; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae | 2016 |
Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cell Count; Cell Survival; Chloramphenicol; Ciprofloxacin; Gentamicins; Growth Charts; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Theoretical; Neisseria gonorrhoeae; Penicillin G; Spectinomycin; Tetracycline; Time Factors | 2016 |
Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
Topics: Adult; Alleles; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gene Expression; Gonorrhea; Humans; Hungary; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Phylogeny; Porins; Prevalence; Spectinomycin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tetracycline; Transferrin-Binding Protein B | 2016 |
Reduced susceptibility to cefixime but not ceftriaxone: an uncertain perspective for the treatment of gonorrhoea in Brazil.
Topics: Adult; Anti-Bacterial Agents; Brazil; Cefixime; Ceftriaxone; Female; Gonorrhea; High-Throughput Nucleotide Sequencing; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Neisseria gonorrhoeae; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Whole Genome Sequencing; Young Adult | 2017 |
Antimicrobial Susceptibility Evaluation and Multiple-Locus Variable Number Tandem Repeat Analysis of Neisseria gonorrhoeae Isolates in China in 2012.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cervix Uteri; Chi-Square Distribution; China; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Neisseria gonorrhoeae; Penicillins; Prevalence; Spectinomycin; Tetracycline; Urethra; Young Adult | 2017 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |
Antimicrobial susceptibility in
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult; Zimbabwe | 2018 |
Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
Topics: Anti-Bacterial Agents; Argentina; Cefixime; Ceftriaxone; Cephalosporin Resistance; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Typing; Neisseria gonorrhoeae; Phylogeny; Sentinel Surveillance; Sequence Analysis, DNA | 2017 |
Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Female; Gonorrhea; Heterosexuality; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Young Adult | 2017 |
High levels of susceptibility to new and older antibiotics in Neisseria gonorrhoeae isolates from Saskatchewan (2003-15): time to consider point-of-care or molecular testing for precision treatment?
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Point-of-Care Systems; Retrospective Studies; Saskatchewan; Spectinomycin; Young Adult | 2018 |
Accuracy and reproducibility of the Etest to detect drug-resistant Neisseria gonorrhoeae to contemporary treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Reproducibility of Results | 2018 |
Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cervix Uteri; Ciprofloxacin; Female; Germany; Gonorrhea; Humans; Laboratories; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins; Rectum; Urethra; Vagina; Young Adult | 2018 |
Transfer of a gonococcal β-lactamase plasmid into Neisseria gonorrhoeae belonging to the globally distributed ST1407 lineage.
Topics: beta-Lactamases; Cefixime; Ceftriaxone; Ciprofloxacin; Gene Transfer, Horizontal; Genotype; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Plasmids | 2018 |
Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Japan; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2019 |
Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Europe; Female; Gentamicins; Gonorrhea; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Sentinel Surveillance; Spectinomycin; Young Adult | 2018 |
Recognition of the β-lactam carboxylate triggers acylation of
Topics: Acylation; Alleles; Binding Sites; Catalytic Domain; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Gonorrhea; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Serine-Type D-Ala-D-Ala Carboxypeptidase | 2019 |
Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
Topics: Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Codon; Evolution, Molecular; Gonorrhea; Humans; Neisseria gonorrhoeae; United States | 2020 |
Antimicrobial resistance of Neisseria gonorrhoeae in Jakarta, Indonesia: a cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Indonesia; Levofloxacin; Male; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline | 2020 |
First Case of High-Level Azithromycin-Resistant Neisseria gonorrhoeae in North Carolina.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; HIV Seronegativity; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; North Carolina; Penicillins; Pharynx; Tetracycline; Whole Genome Sequencing | 2020 |
Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Demography; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin G; Population Surveillance; Sentinel Surveillance; Spectinomycin; Tetracycline; Uganda | 2020 |
Cephalosporin-Resistant Neisseria gonorrhoeae Isolated in Portugal, 2019.
Topics: Adult; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Portugal | 2020 |
External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Germany; Gonorrhea; Humans; Laboratories; Laboratory Proficiency Testing; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Quality Control; Reference Standards; Surveys and Questionnaires | 2020 |
Notes from the Field: First Case in the United States of Neisseria gonorrhoeae Harboring Emerging Mosaic penA60 Allele, Conferring Reduced Susceptibility to Cefixime and Ceftriaxone.
Topics: Alleles; Cefixime; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; United States | 2020 |
Associations between antimicrobial susceptibility/resistance of Neisseria gonorrhoeae isolates in European Union/European Economic Area and patients' gender, sexual orientation and anatomical site of infection, 2009-2016.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; European Union; Female; Gonorrhea; Heterosexuality; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sex Factors; Sexual and Gender Minorities; Sexual Behavior | 2021 |
Tracking Antimicrobial Resistance in Neisseria gonorrhoeae from the Molecular Level Using Endocervical Swabs.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pregnancy; Spectinomycin | 2022 |
Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gonorrhea; Heterosexuality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Docking Simulation; Neisseria gonorrhoeae; Thailand | 2021 |
Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Female; Gentamicins; Gonorrhea; Humans; Malawi; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Polymorphism, Single Nucleotide; Spectinomycin; Tetracycline; Treatment Outcome | 2022 |
Is there an association between previous infection with
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cross-Sectional Studies; Drug Resistance, Bacterial; England; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance; Sexual and Gender Minorities | 2023 |
Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; China; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae | 2022 |
WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Neisseria gonorrhoeae; World Health Organization | 2021 |
Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Europe; Genomics; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities | 2022 |
Significant increase in azithromycin "resistance" and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharyngitis; Sexual and Gender Minorities | 2022 |
Resistance-Guided Therapy for Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates From Peru, 2018 and 2019.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Peru; Spectinomycin | 2022 |
Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Sequence Analysis; Spectinomycin; Tetracycline; Thailand | 2022 |
Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Levofloxacin; Tetracycline | 2022 |
Characterizing the Rise of Disseminated Gonococcal Infections in California, July 2020-July 2021.
Topics: Adult; Anti-Bacterial Agents; California; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2023 |
Isolation, identification and antibiotic resistance profile of thermophilic Campylobacter species from Bovine, Knives and personnel at Jimma Town Abattoir, Ethiopia.
Topics: Abattoirs; Agar; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Cattle; Cefixime; Ceftriaxone; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Microbial; Ethiopia; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Tetracycline | 2022 |
Multicentre Clinical Evaluation of a Molecular Diagnostic Assay to Identify Neisseria gonorrhoeae Infection and Detect Antimicrobial Resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pathology, Molecular | 2023 |
Frequency and Antibiotics Sensitivity Pattern of Culture-Positive Salmonella Typhi in Children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Child; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2023 |
Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Taiwan | 2023 |
Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sexual and Gender Minorities | 2023 |
Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Cities; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny | 2023 |
Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae | 2023 |
Correlates of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gonorrhea; HIV Infections; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quebec; Sentinel Surveillance; Sexual and Gender Minorities | 2023 |
The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Spectinomycin; Urethritis | 2023 |
Use of genome sequencing to resolve differences in gradient diffusion and agar dilution antimicrobial susceptibility testing performance of
Topics: Agar; Alberta; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Ciprofloxacin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Retrospective Studies; Tetracycline | 2023 |